An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19

An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19

Bibliographic Details
Main Authors:	Katheron Intson, Sachin A. Kumar, Amy Botta, Rachael Neckels, Connie Leung, Ali Jawaid
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2020-04-01
Series:	Swiss Medical Weekly
Subjects:	COVID-19 trial hydroxychloroquine azithromycin re-analysis critical appraisal
Online Access:	https://www.smw.ch/index.php/smw/article/view/2769

Similar Items

Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials
by: Nathália Mariana Santos Sansone, et al.
Published: (2024-09-01)

CLINICAL OUTCOMES AND ADVERSE DRUG REACTIONS IN COVID-19 PATIENTS TREATED WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ALONE OR COMBINED
by: H. Rathi, et al.
Published: (2021-11-01)

Hydroxychloroquine and azithromycin use in COVID-19 era and cardiovascular concerns: Current perspective
by: Aditya Kapoor, et al.
Published: (2021-01-01)

Prophylactic Effect of Chloroquine and Hydroxychloroquine on COVID-19 Treatment
by: Amin Ataie, et al.
Published: (2022-04-01)

Proarrhythmia assessment in treatment with hydroxychloroquine and azithromycin hospitalized elderly COVID-19 patients - our experience
by: Raffaele Costa, et al.
Published: (2021-06-01)

Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
by: Chunfeng Li, et al.
Published: (2020-08-01)

Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan
by: Kazimieras Maneikis, et al.
Published: (2021-02-01)

Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
by: Ronaldo C. Go, et al.
Published: (2022-09-01)

Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
by: A.J.J. Lammers, et al.
Published: (2020-12-01)

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
by: Archana Ramireddy, et al.
Published: (2020-06-01)

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
by: Pradeesh Sivapalan, et al.
Published: (2020-06-01)

Effect of hydroxychloroquine and azithromycin combination use in COVID-19 patients – An umbrella review
by: Kaushik Nag, et al.
Published: (2024-01-01)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
by: Niti Mittal, et al.
Published: (2021-01-01)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
by: Lagier JC, et al.
Published: (2022-05-01)

Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan
by: Pradeesh Sivapalan, et al.
Published: (2020-10-01)

Covid-19: Effects of Azithromycin/Hydroxychloroquine/Ivermectin in ambulatory and hospitalized patients
by: Henry Mejia-Zambrano, et al.
Published: (2021-10-01)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
by: Sarah Grewal, et al.
Published: (2020-09-01)

Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
by: Usha Yendrapalli, et al.
Published: (2021-11-01)

QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia
by: Rizki A. Gumilang, et al.
Published: (2021-10-01)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
by: Nobuaki Mori, et al.
Published: (2021-02-01)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
by: Elisa Baranski Lamback, et al.
Published: (2021-03-01)

Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review
by: C. Prodromos, et al.
Published: (2020-11-01)

Study of the structural, chemical descriptors and optoelectronic properties of the drugs Hydroxychloroquine and Azithromycin
by: G.W. Ejuh, et al.
Published: (2020-08-01)

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
by: Rouamba T, et al.
Published: (2021-11-01)

Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs
by: O. V. Gaisenok
Published: (2020-07-01)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
by: Mondher Toumi, et al.
Published: (2020-01-01)

Efficacy and safety of in-hospital treatment of Covid-19 infection with low-dose hydroxychloroquine and azithromycin in hospitalized patients: A retrospective controlled cohort study
by: Gert Meeus, et al.
Published: (2023-10-01)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
by: Philippe Brouqui, et al.
Published: (2023-10-01)

A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Réunion Island
by: Arthur Dubernet, et al.
Published: (2020-12-01)

Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?
by: E. Chabrière
Published: (2021-01-01)

The impact of hydroxychloroquine–azithromycin combination on Tpeak‐to‐end and Tpeak‐to‐end/QT ratio during a short treatment course
by: Nijad Bakhshaliyev, et al.
Published: (2021-07-01)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
by: Matthieu Million, et al.
Published: (2023-04-01)

Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates
by: Celine Boschi, et al.
Published: (2021-12-01)

Short-term, high-dose hydroxychloroquine corneal toxicity
by: Daniel E. Savage, et al.
Published: (2020-06-01)

Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
by: Christine Johnston, et al.
Published: (2021-03-01)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01)

Critical Appraisal of Randomized Controlled Trials: An Overview
by: Harish M Maheshwarappa, et al.
Published: (2023-06-01)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
by: Manuela Monti, et al.
Published: (2020-12-01)

Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration
by: Wener Li, et al.
Published: (2022-02-01)

Critical Appraisal of the Published Clinical Trials on "The Effect of Herbal Medicine on Striae Gravidarum"
by: Somayeh Alirezaei, et al.
Published: (2022-04-01)